UBE2Q1-AS1

Across TCGA pan-cancer cohorts, UBE2Q1-AS1 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated UBE2Q1-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher UBE2Q1-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated UBE2Q1-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

BLCA, HNSC, and ACC are the cancer types where UBE2Q1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.774	0.642	<.001	112	view →
HNSC	DFS	Quartile	II,III,IV	0.542	0.240	<.001	111	view →
ACC	OS	Tertile	All	0.249	0.814	<.001	100	view →
KIRC	DFS	Median	All	0.551	0.692	<.001	82	view →
COAD	DFS	Tertile	All	0.356	0.723	<.001	54	view →
LGG	DFS	Tertile	All	0.773	0.903	<.001	36	view →
CESC	DFS	Tertile	III,IV	0.518	0.836	.010	20	view →
STAD	DFS	Quartile	IV	0.110	0.687	.004	15	view →
SKCM	OS	Tertile	IV	0.923	0.389	.009	14	view →
UVM	DFS	Tertile	III,IV	0.253	0.759	.014	13	view →
READ	DFS	Median	IV	0.361	0.798	.001	12	view →
UCS	DFS	Tertile	IV	0.956	0.381	.024	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

UBE2Q1-AS1–BLCA (OS)

Open the BLCA breakdown →